BALDWIN BROTHERS LLC/MA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2023$18,385
-4.5%
2150.0%0.00%
-50.0%
Q3 2023$19,260
+5.2%
2150.0%0.00%0.0%
Q2 2023$18,305
-4.2%
215
-6.9%
0.00%0.0%
Q1 2023$19,115
+5.2%
2310.0%0.00%0.0%
Q4 2022$18,168
-17.4%
231
-23.3%
0.00%
-33.3%
Q3 2022$22,000
+10.0%
3010.0%0.00%0.0%
Q2 2022$20,000
-20.0%
301
-23.8%
0.00%0.0%
Q1 2022$25,000
+19.0%
3950.0%0.00%
+50.0%
Q4 2021$21,000
-25.0%
3950.0%0.00%
-33.3%
Q3 2021$28,000
+7.7%
3950.0%0.00%0.0%
Q2 2021$26,000
-49.0%
395
-13.2%
0.00%
-50.0%
Q1 2021$51,000
-16.4%
455
-11.0%
0.01%
-25.0%
Q4 2020$61,000
+35.6%
5110.0%0.01%
+33.3%
Q3 2020$45,000
-31.8%
511
-30.5%
0.01%
-40.0%
Q2 2020$66,000
-33.3%
735
-25.8%
0.01%
-41.2%
Q1 2020$99,000
-13.2%
9900.0%0.02%
+6.2%
Q4 2019$114,000
-10.9%
990
-2.7%
0.02%
-15.8%
Q3 2019$128,000
-77.8%
1,017
-78.8%
0.02%
-77.6%
Q2 2019$576,000
+11.6%
4,789
-18.8%
0.08%
+10.4%
Q1 2019$516,000
-56.7%
5,899
-50.4%
0.08%
-61.5%
Q4 2018$1,191,000
-12.7%
11,9030.0%0.20%
+4.7%
Q3 2018$1,364,000
+19.4%
11,903
-6.5%
0.19%
+7.9%
Q2 2018$1,142,0000.0%12,736
-18.4%
0.18%
-4.3%
Q1 2018$1,142,000
+9.8%
15,610
-12.8%
0.18%
+14.2%
Q4 2017$1,040,000
+29.5%
17,9050.0%0.16%
+25.6%
Q3 2017$803,000
+13.6%
17,9050.0%0.13%
+13.2%
Q2 2017$707,000
-2.6%
17,9050.0%0.11%
-5.0%
Q1 2017$726,000
+0.8%
17,9050.0%0.12%
-7.7%
Q4 2016$720,000
+11.1%
17,9050.0%0.13%
+10.2%
Q3 2016$648,000
+548.0%
17,905
+475.9%
0.12%
+594.1%
Q3 2015$100,000
-27.0%
3,109
-6.0%
0.02%
-15.0%
Q2 2015$137,000
-8.1%
3,3090.0%0.02%
-9.1%
Q1 2015$149,000
-13.9%
3,309
-19.4%
0.02%
-21.4%
Q4 2013$173,000
+45.4%
4,106
+38.1%
0.03%
+27.3%
Q3 2013$119,0002,9740.02%
Other shareholders
HAEMONETICS CORP shareholders Q1 2019
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders